Skip to main content
Clinical Trials/ITMCTR2000003785
ITMCTR2000003785
Not yet recruiting
Phase 1

Standardized research and clinical efficacy evaluation of treatment of interstitial lung disease based on lung-collateral theory

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
interstitial lung disease
Sponsor
Shanghai Pulmonary Hospital
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Meet the western medicine diagnosis of the disease;
  • 2\. Meet the TCM diagnosis and syndrome differentiation standards of this disease;
  • 3\. The patient voluntarily accepted the treatment and signed the informed consent.

Exclusion Criteria

  • 1\. Age\> 80 years old;
  • 2\. Combined with tuberculosis, fungus, tumor, etc. and other primary lung diseases;
  • 3\. Patients with severe complications of other diseases such as cardiovascular, urinary, digestive, hematopoietic, endocrine and metabolic systems, liver and kidney insufficiency, and mental illness;
  • 4\. Pregnant or lactating women and those who are known to be allergic to the components of this medicine;
  • 5\. Those who fail to use the prescribed drugs and follow the doctor's advice, cannot judge the curative effect or whose clinical data is incomplete and affect the judgment;
  • 6\. Participating in other drug clinical trials.

Outcomes

Primary Outcomes

Not specified

Similar Trials